Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Common Stock
Additional Paid in Capital (Deficit)
Retained Deficit
Retained Deficit
Cumulative Effect Period of Adoption Adjustment
Beginning Balance at Sep. 28, 2019 $ (887,357) $ 12 $ 157 $ (279,848) $ (607,666) $ 12
Beginning Balance, Shares at Sep. 28, 2019     156,500,000      
Equity-based compensation 1,785     1,785    
Net income 58,561       58,561  
Ending Balance at Oct. 03, 2020 (826,999)   $ 157 (278,063) (549,093)  
Ending Balance, Shares at Oct. 03, 2020     156,500,000      
Issuance of common stock upon initial public offering, net of offering costs 458,587   $ 30 458,557    
Issuance of common stock upon initial public offering, net of offering costs, Shares     30,000,000      
Issuance of common stock under the Plan, shares     3,321,000      
Issuance of common stock under the Plan 3   $ 3      
Equity-based compensation 24,217     24,217    
Net income 126,634       126,634  
Ending Balance at Oct. 02, 2021 (217,558)   $ 190 204,711 (422,459)  
Ending Balance, Shares at Oct. 02, 2021     189,821,000      
Issuance of common stock under the Plan, shares     1,160,000      
Issuance of common stock under the Plan 1,378   $ 1 1,377    
Equity-based compensation 11,346     11,346    
Repurchase and retirement of common stock, shares     (7,500,000)      
Repurchase and retirement of common stock (152,146)   $ (8) (127,500) (24,638)  
Net income 159,029     159,029    
Ending Balance at Oct. 01, 2022 $ (197,951)   $ 183 $ 89,934 $ (288,068)  
Ending Balance, Shares at Oct. 01, 2022     183,481,000